Thirty-four novel mutations detected in factor VIII gene by multiplex CSGE: modeling of 13 novel amino acid substitutions

被引:25
作者
Habart, D
Kalabova, D
Novotny, M
Vorlova, Z
机构
[1] Inst Hematol & Blood Transfus, CR-12820 Prague 2, Czech Republic
[2] Charles Univ Prague, Dept Physiol & Dev Biol, Prague, Czech Republic
[3] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden
关键词
factor VIII; molecular modeling; mutation;
D O I
10.1046/j.1538-7836.2003.00149.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Detection of causal mutations is required for genetic counseling. Molecular modeling combined with patients' phenotype provides significant insight into structure-function relationship of factor (F)VIII molecule. Our objective was to identify defects in the gene of FVIII by a sensitive and simple scanning technique with high throughput in order to study Molecular mechanisms by which novel amino acid substitutions may lead to hemophilia A. A cohort of 81 families with mild, moderate and severe hemophilia A negative in intron 22 inversion was studied. For detection of mutations in the FVIII gene a conformation sensitive gel electrophoresis (CSGE) was modified by multiplexing. Thirteen novel amino acid substitutions were studied by molecular modeling and a correlation with the cross-reactive material (CRM) phenotype was performed. In 74 families, 59 different mutations were detected. Six different mutations were recurrent in 21 unrelated families. Thirty-four novel mutations included 19 point mutations, four small insertions. nine small deletions and two complex mutations. Thirteen novel amino acid substitutions occurred at residues conserved in FVIII orthologs. Five of them were associated with a discrepancy between FVIII activity and antigen; another five with CRM reduced phenotype and one with undetectable FVIII antigen. Multiplexing of the CSGE significantly increased its throughput without substantial loss of sensitivity. Molecular modeling suggested mechanisms by which substitutions at residues 382 and 569, located outside the proposed FIXa-binding region. may influence FVIII/FIXa interaction. His2155 was predicted to participate in FVIII/VFW binding.
引用
收藏
页码:773 / 781
页数:9
相关论文
共 43 条
[21]   Hemophilic factor VIIIC1-and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure [J].
Liu, ML ;
Shen, BW ;
Nakaya, S ;
Pratt, KP ;
Fujikawa, K ;
Davie, EW ;
Stoddard, BL ;
Thompson, AR .
BLOOD, 2000, 96 (03) :979-987
[22]   Crystal structures of the membrane-binding C2 domain of human coagulation factor V [J].
Macedo-Ribeiro, S ;
Bode, W ;
Huber, R ;
Quinn-Allen, MA ;
Kim, SW ;
Ortel, TL ;
Bourenkov, GP ;
Bartunik, HD ;
Stubbs, MT ;
Kane, WH ;
Fuentes-Prior, P .
NATURE, 1999, 402 (6760) :434-439
[23]   SPECTRUM OF MUTATIONS IN CRM-POSITIVE AND CRM-REDUCED HEMOPHILIA-A [J].
MCGINNISS, MJ ;
KAZAZIAN, HH ;
HOYER, LW ;
BI, L ;
INABA, H ;
ANTONARAKIS, SE .
GENOMICS, 1993, 15 (02) :392-398
[24]  
Mertens K, 1999, THROMB HAEMOSTASIS, V82, P209
[25]   Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism [J].
Morichika, S ;
Shima, M ;
Kamisue, S ;
Tanaka, I ;
Imanaka, Y ;
Suzuki, H ;
Shibata, H ;
Pemberton, S ;
Gale, K ;
McVey, J ;
Tuddenham, EGD ;
Yoshioka, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) :901-906
[26]  
Oldenburg J, 2001, THROMB HAEMOSTASIS, V85, P577
[27]   Evaluation of DHPLC in the analysis of hemophilia A [J].
Oldenburg, J ;
Ivaskevicius, V ;
Rost, S ;
Fregin, A ;
White, K ;
Holinski-Feder, E ;
Müller, CR ;
Weber, BHF .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2001, 47 (1-2) :39-51
[28]   A molecular model for the triplicated a domains of human factor VIII based on the crystal structure of human ceruloplasmin [J].
Pemberton, S ;
Lindley, P ;
Zaitsev, V ;
Card, G ;
Tuddenham, EGD ;
KemballCook, G .
BLOOD, 1997, 89 (07) :2413-2421
[29]   Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa [J].
Pipe, SW ;
Saenko, EL ;
Eickhorst, AN ;
Kemball-Cook, G ;
Kaufman, RJ .
BLOOD, 2001, 97 (03) :685-691
[30]   Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin [J].
Pipe, SW ;
Morris, JA ;
Shah, J ;
Kaufman, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) :8537-8544